Evidence map›Paper›PMID 42189882›Full record

ArticlePLoS pathogens2026

Outer membrane vesicles hijack TIM-1 for cellular uptake.

Craig R MacNair, Varnesh Tiku, Shengya Cao, Ariana D Sanchez, Barath Udayasuryan, Katharina Theresa Kroll, Adarsh Singh, Man-Wah Tan

Abstract read
In one paragraph

Article in PLoS pathogens, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Craig R MacNairInfectious Diseases and Host-Microbe Interactions Department, Genentech Inc., San Francisco, California, United States of America.ORCID https://orcid.org/0000-0002-3558-438X
Varnesh TikuInfectious Diseases and Host-Microbe Interactions Department, Genentech Inc., San Francisco, California, United States of America.
Shengya CaoMicrochemistry, Proteomics and Lipidomics, Genentech, San Francisco, California, United States of America.
Ariana D SanchezMicrochemistry, Proteomics and Lipidomics, Genentech, San Francisco, California, United States of America.
Barath UdayasuryanInfectious Diseases and Host-Microbe Interactions Department, Genentech Inc., San Francisco, California, United States of America.
Katharina Theresa KrollInfectious Diseases and Host-Microbe Interactions Department, Genentech Inc., San Francisco, California, United States of America.
Adarsh SinghInfectious Diseases and Host-Microbe Interactions Department, Genentech Inc., San Francisco, California, United States of America.
Man-Wah TanInfectious Diseases and Host-Microbe Interactions Department, Genentech Inc., San Francisco, California, United States of America.ORCID https://orcid.org/0000-0002-7748-212X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Outer membrane vesicles (OMVs) are nanoscale proteoliposomes shed by Gram-negative bacteria that mediate host-pathogen interactions and hold promise as platforms for vaccines and targeted drug delivery. Despite their biological and translational significance, the cellular mechanisms governing OMV entry into host cells remain poorly understood. Here, we demonstrate that E. coli OMVs are internalized by epithelial cells via clathrin-mediated, receptor-dependent endocytosis. Using a high-throughput screen of over 1,500 human single-pass transmembrane proteins, we identify T-cell immunoglobulin and mucin-domain 1 (TIM-1) as a strong OMV-binding receptor. Functional validation revealed that TIM-1 overexpression markedly increased OMV uptake, whereas TIM-1 knockout and antibody-mediated blockade significantly impaired internalization across multiple cell lines. Mechanistic studies demonstrate that TIM-1 binds to lipopolysaccharide (LPS) on the OMV surface via its phosphatidylserine-binding domain. Uptake of OMVs by TIM-1 triggers proinflammatory cytokine production which can be reduced by preventing this interaction. Additionally, OMVs from multiple bacterial species hijack TIM-1 for entry, making it an intriguing antivirulence strategy. Our findings establish TIM-1 as a critical host receptor mediating OMV uptake and provide a novel approach to modulate vesicle-driven pathogenesis and enhance OMV-based therapies.

Indexed as

EndocytosisEscherichia coliHepatitis A Virus Cellular Receptor 1Host-Pathogen InteractionsAnimalsEpithelial CellsHumansLipopolysaccharidesHAVCR1 protein, humanHepatitis A Virus Cellular Receptor 1Lipopolysaccharides

Identifiers

PMID42189882
PMCPMC13225658

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.